Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antitussive |
| gptkbp:ATCCode |
gptkb:R05DB13
|
| gptkbp:brand |
Codelac Neo
Sinecod |
| gptkbp:CASNumber |
151-40-2
|
| gptkbp:chemicalFormula |
C18H29NO2
|
| gptkbp:contraindication |
children under 2 years
hypersensitivity to butamirate |
| gptkbp:eliminationHalfLife |
6 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
butamirate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
cough center suppressant
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea drowsiness skin rash |
| gptkbp:usedFor |
cough suppression
|
| gptkbp:bfsParent |
gptkb:R05CB01
|
| gptkbp:bfsLayer |
7
|